FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns a pharmaceutical composition possessing antihypoxic properties, improving coronary and cerebral circulation, improving cognitive functions, having antioxidant, antiischemic and hypolipidemic action, containing as active substances a therapeutically effective amount of 2-ethyl-6-methyl-3-oxypyridine succinate and atorvastatin, as well as pharmaceutically acceptable target additives applicable in solid dosage forms containing: a group of excipients and strength enhancing agents: lactose, dibasic calcium phosphate or microcrystalline cellulose, a group of binding substances: starch, polyvinylpyrrolidone or oxypropylmethylcellulose, a group of substances providing adequate flowability and preventing adhesion - aerosil, calcium stearate, magnesium stearate. The composition is presented in the solid dosage form such as a powder, a granule, a capsule or a tablet.
EFFECT: composition shows high bioavailability.
6 cl, 7 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
HEPATOPROTECTOR FOR TREATING NON-ALCOHOLIC LIVER DISEASE IN TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2537227C1 |
ANTIHYPOXIC AND HYPOLIPIDEMIC PHARMACEUTICAL AGENT IMPROVING CORONARY AND CEREBRAL BLOOD FLOW | 2013 |
|
RU2536275C1 |
METHOD OF TREATING NON-ALCOHOLIC LIVER DISEASE ACCOMPANYING TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2538221C1 |
ANTI-HYPOXIC AGENT | 2012 |
|
RU2497522C1 |
2-ETHYL-6-METHYL-3-OXYPYRIDINE SUCCINATE COMPOSITION OF CYTOPROTECTION MEDICATION | 2007 |
|
RU2357730C1 |
HYPOLIPIDEMIC AND ANTIISHEMIC AGENT "SERPYSTEN" | 2007 |
|
RU2337701C1 |
PHARMACEUTICAL NEUROPROTECTIVE, ANTIOXIDANT, ANTIHYPOXIC, ANTIAPOPTOTIC AND MEMBRANE PROTECTIVE COMPOSITION AND METHOD OF TREATMENT | 2008 |
|
RU2385722C1 |
PHARMACEUTICAL COMBINATION OF ATORVASTATIN AND NICERGOLIN FOR PREVENTING OR TREATING CEREBROVASCULAR DISEASE | 2011 |
|
RU2481124C1 |
NOVEL 3-HYDROXYPYRIDINE DERIVATIVE HAVING LIPID REGULATING ACTIVITY | 2020 |
|
RU2743923C1 |
ANTIOXIDANT PREPARATION FOR TREATMENT AND PREVENTION OF CARDIAC PATHOLOGIES IN ANIMALS | 2023 |
|
RU2818764C1 |
Authors
Dates
2012-03-20—Published
2010-11-09—Filed